Goblet cell transplantation using autologous turbinate nasal mucosa is a promising treatment for severe ocular surface diseases.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.